Table 5.
AP biomarkers obtained from the Bai et al. model and the Grandi et al. model under atrial fibrillation (AF) and sinus rhythm (SR) conditions.
| Biomarkers | Bai et al. Model | Grandi et al. Model | ||
|---|---|---|---|---|
| SR (n = 745) | AF (n = 621) | SR (n = 170) | AF (n = 87) | |
| APD90 (ms) | 250.10 ± 41.59 | 181.93 ± 23.66 | 251.08 ± 61.50 | 241.82 ± 37.98 |
| APD50 (ms) | 187.84 ± 32.36 | 121.22 ± 24.13 | 66.30 ± 29.74 | 52.45 ± 22.18 |
| RMP (mV) | −79.28 ± 3.29 | −79.81 ± 3.22 | −81.01± 0.18 | −81.03 ± 0.23 |
| dVdtmax(V/s) | 197.87 ± 83.18 | 219.21 ± 90.48 | 351.14 ± 48.90 | 368.66 ± 52.15 |
Note: Values are presented as mean ± standard error. AP biomarkers include APD50, APD90, RMP, and dVdtmax. Abbreviations: dVdtmax: Maximum upstroke velocity, RMP: Resting membrane potential, and APD50 and APD90: AP duration at 50% and 90%, respectively.